Breaking from AACR: Profiling the TCR Beta Repertoire in NSCLC Donors

TCRβ sequencing is currently being explored in oncology research as a potential predictor for patient response to immunotherapies.   Researchers from Biodesix, Inc. shared their most recent findings in this area at the AACR Advances in Liquid Biopsies conference in Miami from January 13–16, 2020. The research, co-authored by Astarte’s Benjamin Tjoa, evaluated peripheral blood lymphocytes […]

Key Biologics and Astarte Biologics Merge

Includes growth equity investment from Ampersand Capital Partners MEMPHIS, TN and BOTHEL, WA – August 7, 2018 – Key Biologics has completed its merger with Astarte Biologics to create the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry. In conjunction with the merger the new entity […]